Position in NBIX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,791,580
+$1,390,300 QoQ
Shares Held
10,630
+249.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#326
of 768 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Mar 31, 2026CallValue
$329,350
CallShares
2,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $24,089,483 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
370,092 | $9,389,234 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,697 | $3,628,635 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
293,670 | $2,325,866 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
10,630 | $1,791,580 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,304 | $1,534,899 | |
| 6 | ZTS |
Zoetis Inc.
|
18,525 | $1,331,206 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
34,027 | $1,231,777 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
27,400 | $991,880 |
All Filings in NBIX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,791,580 | 10,630 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $329,350 | 2,500 | Call | Defined | 2026-05-08 | |
| 2026-03-31 | $401,280 | 3,046 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $6,520,776 | 45,976 | Shares | Defined | 2026-02-09 | |
| 2025-03-31 | $497,700 | 4,500 | Shares | Defined | 2025-05-08 | |
| 2024-09-30 | $505,815 | 4,390 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $658,062 | 4,780 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $818,555 | 5,935 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $873,041 | 6,626 | Shares | Defined | 2024-05-06 | |
| 2022-12-31 | $1,733,193 | 14,511 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||